ATE551063T1 - Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen - Google Patents

Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen

Info

Publication number
ATE551063T1
ATE551063T1 AT07704583T AT07704583T ATE551063T1 AT E551063 T1 ATE551063 T1 AT E551063T1 AT 07704583 T AT07704583 T AT 07704583T AT 07704583 T AT07704583 T AT 07704583T AT E551063 T1 ATE551063 T1 AT E551063T1
Authority
AT
Austria
Prior art keywords
bifidobacterium longum
inflammation
prophylaxis
treatment
baaa
Prior art date
Application number
AT07704583T
Other languages
English (en)
Inventor
Annick Mercenier
Stephanie Blum-Sperisen
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE551063T1 publication Critical patent/ATE551063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT07704583T 2006-02-15 2007-02-14 Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen ATE551063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06101690 2006-02-15
PCT/EP2007/051448 WO2007093619A1 (en) 2006-02-15 2007-02-14 Use of bifidobacterium longum for the prevention and treatment of inflammation

Publications (1)

Publication Number Publication Date
ATE551063T1 true ATE551063T1 (de) 2012-04-15

Family

ID=36636972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07704583T ATE551063T1 (de) 2006-02-15 2007-02-14 Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen

Country Status (16)

Country Link
US (2) US8916145B2 (de)
EP (1) EP1986669B1 (de)
CN (1) CN101420965B (de)
AT (1) ATE551063T1 (de)
AU (1) AU2007216461B2 (de)
BR (1) BRPI0707937A2 (de)
CA (1) CA2642431A1 (de)
ES (1) ES2381211T3 (de)
MX (1) MX2008010422A (de)
MY (1) MY148872A (de)
PH (1) PH12012500739A1 (de)
PL (1) PL1986669T3 (de)
PT (1) PT1986669E (de)
RU (1) RU2445362C2 (de)
WO (1) WO2007093619A1 (de)
ZA (1) ZA200807879B (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
EP2124966B1 (de) 2007-02-01 2015-09-09 IAMS Europe B.V. Verfahren zur verringerung von entzündung und oxidativem stress bei einem säugetier mit glucose-antimetaboliten, avocado oder avocado-extrakten
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP2110028A1 (de) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum und hippocampale BDNF-Expression
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2318513B1 (de) * 2008-07-11 2012-09-19 Chr. Hansen A/S Neues probiotisches bifidobacterium longum
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
EP2438821B1 (de) * 2008-11-03 2020-01-15 Société des Produits Nestlé S.A. Nährmittel umfassend probiotika und das schlafmuster verbessernd
CN102984955B (zh) * 2008-11-11 2015-01-07 营养健康有限公司 长双歧杆菌
EP2251022A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Nicht-replizierte Mikroorganismen und deren immunstärkender Effekt
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
EP2251020A1 (de) * 2009-05-11 2010-11-17 Nestec S.A. Kurzzeitige Hochtemperaturbehandlung erzeugt mikrobielle Zubereitungen mit entzündungshemmenden Profilen
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
PT2467032T (pt) * 2009-08-18 2018-04-04 Nestec Sa Composição nutricional compreendendo estirpes de bifidobacterium longum e que reduz os sintomas de alergia alimentar, especialmente em lactentes e crianças
TR201807143T4 (tr) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
EP2308499A1 (de) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) und Gewichtskontrolle
JP5600179B2 (ja) * 2009-11-11 2014-10-01 アリメンタリー、ヘルス、リミテッド ビフィズス菌株
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
WO2012003351A2 (en) 2010-07-02 2012-01-05 The Procter & Gamble Company Web material and method for making same
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
CA2803382C (en) 2010-07-02 2015-03-31 The Procter & Gamble Company Method for delivering an active agent
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
EP2449887B1 (de) * 2010-11-05 2016-01-06 Nestec S.A. Verfahren zur Herstellung von Haustierfutter enthaltend probiotische Mikroorganismen
EP2455092A1 (de) * 2010-11-11 2012-05-23 Nestec S.A. Nicht replizierende probiotische Mikroorganismen als Schutz vor Infektionen der oberen Atemwege
CA2839524C (en) 2011-06-20 2016-05-17 H.J. Heinz Company Probiotic compositions and methods
CN103889239A (zh) * 2011-10-18 2014-06-25 雀巢产品技术援助有限公司 用于促进肠血管生成和营养吸收和经肠喂养耐受性和/或预防和/或治疗肠炎、和/或肠损伤和手术后恢复的组合物
CN103820357A (zh) * 2013-12-30 2014-05-28 上海交大昂立股份有限公司 一株长双歧杆菌及其防治食物过敏的功能
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物
BR112018000934B1 (pt) * 2015-08-31 2022-02-01 Société des Produits Nestlé S.A. Usos de bifidobacterium longum para tratar ou prevenir sintomas depressivos
CA3008195A1 (en) * 2015-12-14 2017-06-22 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
MX380853B (es) 2017-01-27 2025-03-12 Procter & Gamble Composiciones en la forma de estructuras solidas solubles
MX380727B (es) 2017-01-27 2025-03-12 Procter & Gamble Composiciones en la forma de estructuras sólidas solubles que comprenden partículas aglomeradas efervescentes.
US11660321B2 (en) * 2017-01-31 2023-05-30 University-Industry Cooperation Group Of Kyung Hee University Method of treatment with lactic acid bacteria
CN110650723A (zh) 2017-05-16 2020-01-03 宝洁公司 可溶性固体结构形式的调理毛发护理组合物
BR112020010929A2 (pt) * 2017-12-29 2020-11-17 Société des Produits Nestlé S.A. produção de serpina
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
CA3114973A1 (en) * 2018-10-02 2020-04-09 Societe Des Produits Nestle S.A. Probiotic combination for treatment of inflammatory-related gastrointestinal disorders
US20220000947A1 (en) * 2018-12-21 2022-01-06 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
WO2020264574A1 (en) 2019-06-28 2020-12-30 The Procter & Gamble Company Dissolvable solid fibrous articles containing anionic surfactants
WO2021001368A1 (en) * 2019-07-01 2021-01-07 Société des Produits Nestlé S.A. Serpin production
WO2021001367A1 (en) * 2019-07-01 2021-01-07 Société des Produits Nestlé S.A. Serpin production
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
KR102343938B1 (ko) * 2020-09-02 2021-12-28 주식회사 비피도 재조합 비피도박테리움 비피덤 bgn4를 포함하는 염증 개선용 조성물
CN112159784A (zh) * 2020-10-29 2021-01-01 佛山市朗芯生物科技有限公司 长双歧杆菌nx-4及其在制备治疗和/或预防过敏性疾病药物中的应用
CH718355A2 (fr) * 2021-02-16 2022-08-31 Nestle Sa Composition et kit pour soulager les symptômes de l'allergie respiratoire.
EP4395730A1 (de) 2021-08-30 2024-07-10 The Procter & Gamble Company Lösliche feste struktur mit ersten und zweiten polymerstrukturierungsmitteln
EP4447893A1 (de) 2021-12-17 2024-10-23 The Procter & Gamble Company Lösliche feste faserige shampooartikel mit salzen
CN114574390B (zh) * 2022-03-09 2024-03-01 江南大学 一株缓解结肠炎的长双歧杆菌婴儿亚种及应用
WO2023173048A1 (en) 2022-03-10 2023-09-14 The Procter & Gamble Company Dissolvable solid structure having first and second layers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
ATE172245T1 (de) 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PT862863E (pt) 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
EP1034787A1 (de) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
CN1638650A (zh) * 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
RU2210592C1 (ru) * 2001-12-27 2003-08-20 Российский государственный медицинский университет ШТАММ БАКТЕРИЙ Bifidobacterium longum 58B ДЛЯ ПРИГОТОВЛЕНИЯ БИОЛОГИЧЕСКИ АКТИВНЫХ ДОБАВОК, РЕГУЛИРУЮЩИХ МИКРОФЛОРУ КИШЕЧНИКА У ДЕТЕЙ РАННЕГО ВОЗРАСТА
EP1384483A1 (de) 2002-07-23 2004-01-28 Nestec S.A. Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
EP1759597B1 (de) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotische Zusammensetzung
PT1638414E (pt) * 2003-06-23 2009-07-13 Nestec Sa Fórmula para lactentes ou fórmula de transição
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物

Also Published As

Publication number Publication date
AU2007216461A1 (en) 2007-08-23
ZA200807879B (en) 2009-12-30
US8916145B2 (en) 2014-12-23
US20120201785A1 (en) 2012-08-09
WO2007093619A1 (en) 2007-08-23
CN101420965A (zh) 2009-04-29
PT1986669E (pt) 2012-05-15
MX2008010422A (es) 2008-10-27
US9456630B2 (en) 2016-10-04
PL1986669T3 (pl) 2012-09-28
BRPI0707937A2 (pt) 2011-05-10
US20090274661A1 (en) 2009-11-05
RU2445362C2 (ru) 2012-03-20
PH12012500739A1 (en) 2013-06-17
AU2007216461B2 (en) 2012-08-30
ES2381211T3 (es) 2012-05-24
RU2008136876A (ru) 2010-03-20
MY148872A (en) 2013-06-14
EP1986669A1 (de) 2008-11-05
EP1986669B1 (de) 2012-03-28
CN101420965B (zh) 2013-08-07
CA2642431A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
JO2576B1 (en) Antibodies
IN2012DN01638A (de)
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
MX2010003117A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
IN2012DN00624A (de)
MY147247A (en) Organic compounds and their uses
MA33810B1 (fr) Compositions pour traiter les nausées et vomissements à médiation centrale
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
SMT201600182B (it) Ligandi sigma per l'uso nella prevenzione e/o nel trattamento del dolore post-operatorio
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
MY150931A (en) Substituted oxazolidinones and their use
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2009050677A3 (fr) Utilisation de bacteries lactiques pour la prevention et/ou le traitement de pathologies cutanees
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
IL194353A0 (en) Lysobactin amides
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
NZ596218A (en) Bssl antagonists for treatment of inflammatory diseases